Here's Won't Touch Teva: Why I Pass on the Generic Giant
Teva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Find effective wealth accumulation strategies designed specifically for young professionals. Start building your financial future today.
17,961 articlesTeva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Friday brought a sharp move for algonquin power utilities stock as investors digested a guidance miss for 2027. This ...
RF Industries (RFIL) faces a mix of aerospace, medical, and data-communications demand in 2026. This guide breaks dow...
BNB rose toward the $660 mark as traders push bets higher in an aggressive spot market. Open interest on BNB futures ...
XRP sits around $1.40 as institutions quietly expand tokenized-asset settlements on public rails, even as on-chain ac...
Pi Network’s PI token fell through a key support level, signaling renewed downside pressure. This week’s network (pi)...
Bitcoin wobbled amid renewed volatility as traders weigh key support levels and the risk of capitulation, with analys...
A prominent bitcoin analyst predicts bitcoin could reach $200K within two years, arguing that a near-term bottom is f...
Pi Network rolls out major updates and ecosystem expansions as DOGE and ADA wrestle with selling pressure. This repor...
A record-sized end-of-quarter options expiry is set to roll across Bitcoin and Ethereum, potentially stirring markets...
XRP edges higher toward a key trendline, stoking bets on a breakout. Analysts warn the pattern could unlock a sizable...
XRP prices hover near $1 as July opens, triggering another round of ripple (xrp) price predictions. Traders weigh whe...